The influence of HIV‐related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Introduction: Stigma and disclosure concerns have been key barriers to oral pre‐exposure prophylaxis (PrEP) adherence for African adolescent girls and young women (AGYW) in efficacy trials. We aimed to understand the impact of these factors among African AGYW in an open‐label PrEP study. Methods: HPTN 082 was an open‐label PrEP study among AGYW (ages 16 to 24) in Harare, Zimbabwe, and Cape Town and Johannesburg, South Africa from 2016 to 2018. Women starting PrEP were randomized to standard adherence support (counselling, two‐way SMS, monthly adherence clubs) or standard support plus drug‐level feedback. Serial in‐depth interviews were conducted among 67 AGYW after 13‐week and 26‐week study visits to explore experiences of stigma, disclosure and PrEP adherence. We analysed data by coding transcripts and memo‐writing and diagramming to summarize themes. Results: AGYW described stigma related to sexual activity (e.g. “people say I'm a prostitute”) and being perceived to be living with HIV because of taking antiretrovirals (e.g. “my husband's friends say I'm HIV infected”). Participants who anticipated stigma were reluctant to disclose PrEP use and reported adherence challenges. Disclosure also resulted in stigmatizing experiences. Across all sites, negative descriptions of stigma and disclosure challenges were more common in the first interview. In the second interview, participants often described disclosure as an “empowering” way to combat community‐level PrEP stigma; many said that they proactively discussed PrEP in their communities (e.g. became a “community PrEP ambassador”), which improved their ability to take PrEP and encourage others to use PrEP. These empowering disclosure experiences were facilitated by ongoing HPTN 082 study activities (e.g. counselling sessions, adherence clubs) in which they could discuss PrEP‐related stigma, disclosure and PrEP adherence issues. Conclusions: Stigma and disclosure challenges were initial concerns for African AGYW newly initiating PrEP but many were empowered to disclose PrEP use over their first six months of PrEP use, which helped them cope with stigma and feel more able to take PrEP regularly. PrEP programmes can foster disclosure through community and clinic‐based discussion, adherence clubs and activities normalizing sexual behaviour and PrEP use, which can reduce stigma and improve PrEP adherence and thus effectiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Discovery of Grounded Theory: Strategies for Qualitative Research.
Wagner, H. R., Glaser, B. G., & Strauss, A. L. (1968) · Social Forces · doi:10.2307/2575405 · Cited by 46,361
The Discovery of Grounded Theory; Strategies for Qualitative Research
Glaser, B. G., Strauss, A. L., & Strutzel, E. (1968) · Nursing Research · doi:10.1097/00006199-196807000-00014 · Cited by 39,449
Qualitative Data Analysis: A Methods Sourcebook
Miles, M. B., Huberman, A. M., & Saldaña, J. (1988) · Cited by 20,701
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
Self-citationQualitative Data Analysis for Health Services Research: Developing Taxonomy, Themes, and Theory
Bradley, E. H., Curry, L. A., & Devers, K. J. (2007) · Health Services Research · doi:10.1111/j.1475-6773.2006.00684.x · Cited by 3,437 · cited 1×
“For our thematic analysis, we used the constant comparative method developing an initial codebook from themes in the data and refining the codebook during the coding process [39,40].”
MethodAntiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
Self-citationAntiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110711 · Cited by 1,996
McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., Sullivan, A. K., Clarke, A., Reeves, I., Schembri, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00056-2 · Cited by 1,878
Preexposure Prophylaxis for HIV Infection among African Women
Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., Malahleha, M., Owino, F., Manongi, R., Onyango, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202614 · Cited by 1,603 · cited 1×
“Adherence can be challenging, however, and suboptimal adherence in efficacy trials was largely attributed to concerns around product safety, effectiveness, and anticipated and experienced PrEP stigma [5,7,8].”
BackgroundStigma and its public health implications
Link, B. G., & Phelan, J. C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68184-1 · Cited by 1,498
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., Noguchi, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402269 · Cited by 1,296
PrEP stigma: implicit and explicit drivers of disparity
Golub, S. A. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0385-0 · Cited by 383 · cited 1×
“PrEP may also be seen as promoting sexual promiscuity, leading to stigma related to norms around sexuality in adolescent girls and young women (AGYW) [11,14,15].”
BackgroundGrossoehme, D., & Lipstein, E. (2016) · BMC Research Notes · doi:10.1186/s13104-016-1954-1 · Cited by 304 · cited 1×
“We also utilized a case-specific analytic approach to identify changes in participants’ narratives over time [42,43].”
MethodCottrell, M. L., Yang, K. H., Prince, H. M. A., Sykes, C., White, N., Malone, S., Dellon, E. S., Madanick, R. D., Shaheen, N. J., Hudgens, M. G., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw077 · Cited by 300 · cited 1×
“PrEP acceptance was assessed via PrEP dispensation records and PrEP adherence was defined using plasma drug level data (with tenofovir levels >40 ng/mL considered “high adherence”) [36,37].”
MethodAnderson, P. L., Liu, A. Y., Castillo-Mancilla, J. R., Gardner, E. M., Seifert, S. M., McHugh, C., Wagner, T., Campbell, K., Morrow, M., Ibrahim, M., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01710-17 · Cited by 272 · cited 2×
“Adherence at weeks 13 and 26 was also assessed with dried blood spot data, with tenofovir diphosphate levels (TFVDP) ≥700 fmol/punch consistent with four or more doses per week [38].”
BackgroundMethodVan der Elst, E. M., Mbogua, J., Operario, D., Mutua, G., Kuo, C., Mugo, P., Kanungi, J., Singh, S., Haberer, J., Priddy, F., et al. (2013) · AIDS and Behavior · doi:10.1007/s10461-012-0317-8 · Cited by 271
van der Straten, A., Stadler, J., Montgomery, E., Hartmann, M., Magazi, B., Mathebula, F., Schwartz, K., Laborde, N., & Soto-Torres, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089118 · Cited by 258
Stigma and Shame Experiences by MSM Who Take PrEP for HIV Prevention: A Qualitative Study
Dubov, A., Galbo, P., Altice, F. L., & Fraenkel, L. (2018) · American Journal of Men's Health · doi:10.1177/1557988318797437 · Cited by 241 · cited 1×
“PrEP may also be seen as promoting sexual promiscuity, leading to stigma related to norms around sexuality in adolescent girls and young women (AGYW) [11,14,15].”
BackgroundStigma, Partners, Providers and Costs: Potential Barriers to PrEP Uptake among US Women
Goparaju, L., Praschan, N. C., Jeanpiere, L. W., Experton, L. S., Young, M. A., & Kassaye, S. (2017) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.1000730 · Cited by 227
Eaton, L. A., Kalichman, S. C., Price, D., Finneran, S., Allen, A., & Maksut, J. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1690-0 · Cited by 227 · cited 2×
“Similar concerns about stigma and disclosure have been described in programmatic PrEP delivery settings among heterosexual HIV serodiscordant couples in Nigeria and MSM in the United States, particularly when PrEP is explicitly marketed for “high-risk populations” [14,46,47].”
BackgroundHaberer, J. E., Baeten, J. M., Campbell, J., Wangisi, J., Katabira, E., Ronald, A., Tumwesigye, E., Psaros, C., Safren, S. A., Ware, N. C., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001511 · Cited by 224 · cited 1×
“PrEP acceptance was assessed via PrEP dispensation records and PrEP adherence was defined using plasma drug level data (with tenofovir levels >40 ng/mL considered “high adherence”) [36,37].”
MethodSelf-citationPeng, P., Su, S., Fairley, C. K., Chu, M., Jiang, S., Zhuang, X., & Zhang, L. (2018) · AIDS and Behavior · doi:10.1007/s10461-017-1675-z · Cited by 185
Simoni, J. M., Huh, D., Frick, P. A., Pearson, C. R., Andrasik, M. P., Dunbar, P. J., & Hooton, T. M. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b9300c · Cited by 174 · cited 1×
“Social support interventions are likely key strategies to improve PrEP effectiveness among youth and in-person adherence clubs have been found to improve ART adherence among adolescents living with HIV [61].”
BackgroundCalabrese, S. K., Dovidio, J. F., Tekeste, M., Taggart, T., Galvao, R. W., Safon, C. B., Willie, T. C., Caldwell, A., Kaplan, C., & Kershaw, T. S. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001762 · Cited by 167
An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women
Balkus, J. E., Brown, E., Palanee, T., Nair, G., Gafoor, Z., Zhang, J., Richardson, B. A., Chirenje, Z. M., Marrazzo, J. M., & Baeten, J. M. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000974 · Cited by 161 · cited 1×
“Eligible women were HIV-negative, literate in English, isiXhosa, isiZulu, SeSotho or Shona, and at high risk of HIV as determined by an empiric risk score [33].”
BackgroundSullivan, P. S., Driggers, R. A., Stekler, J. D., Siegler, A. J., Goldenberg, T., McDougal, S. J., Caucutt, J., Jones, J. S., & Stephenson, R. B. (2017) · JMIR mhealth and uhealth · doi:10.2196/mhealth.7199 · Cited by 156
Amico, K. R., Wallace, M., Bekker, L., Roux, S., Atujuna, M., Sebastian, E., Dye, B. J., Elharrar, V., & Grant, R. M. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1458-y · Cited by 155 · cited 2×
“We hypothesized that this sample size would be adequate to achieve saturation of key themes based on qualitative work investigating similar issues of stigma and disclosure among new PrEP users [18,34,35].”
BackgroundResultSelf-citationTung, E. L., Thomas, A., Eichner, A., & Shalit, P. (2018) · Sexual Health · doi:10.1071/sh18084 · Cited by 152
Analysing Qualitative Longitudinal Research in Evaluations
Lewis, J. (2007) · Social Policy and Society · doi:10.1017/s1474746407003880 · Cited by 150 · cited 1×
“We also utilized a case-specific analytic approach to identify changes in participants’ narratives over time [42,43].”
MethodThe Pre-Exposure Prophylaxis-Stigma Paradox: Learning from Canada's First Wave of PrEP Users
Grace, D., Jollimore, J., MacPherson, P. A., Strang, M., & Tan, D. H. S. (2017) · AIDS Patient Care and STDs · doi:10.1089/apc.2017.0153 · Cited by 141 · cited 1×
“Moreover experiences with PrEP-related stigma and disclosure could dynamically shift over time as community knowledge of PrEP increases [20,31,32].”
BackgroundHaire, B. G. (2015) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s72419 · Cited by 136
Walsh, J. L. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2371-3 · Cited by 134 · cited 1×
“Mediation analyses among MSM and transgender women in the United States have shown that stigma has a direct negative association on PrEP adherence and an indirect influence on PrEP use through fears about disclosure, highlighting the importance of both stigma and disclosure on regular PrEP use [22], although similar a…”
ResultParticipants' Explanations for Nonadherence in the FEM-PrEP Clinical Trial
Corneli, A. L., Perry, B., McKenna, K., Agot, K. E., Ahmed, K., Taylor, J., Malamatsho, F., Odhiambo, J. O., Skhosana, J., & Damme, L. V. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000880 · Cited by 132 · cited 1×
“Adherence can be challenging, however, and suboptimal adherence in efficacy trials was largely attributed to concerns around product safety, effectiveness, and anticipated and experienced PrEP stigma [5,7,8].”
Backgroundvan der Straten, A., Stadler, J., Luecke, E. H., Laborde, N. D., Hartmann, M., Montgomery, E., & VOICE‐C Study Team (2014) · Journal of the International AIDS Society · doi:10.7448/ias.17.3.19146 · Cited by 128 · cited 1×
“While this work is unique in its focus on PrEP stigma among African AGYW, our findings are largely consistent with PrEP studies with African adults [7,18,28,45].”
ResultMontgomery, E., van der Straten, A., Stadler, J., Hartmann, M., Magazi, B., Mathebula, F., Laborde, N. D., & Soto-Torres, L. E. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0950-5 · Cited by 126 · cited 2×
“Women in South Africa have cited support from male partners and family members as a facilitator of PrEP use, and have described PrEP stigma, relationship power dynamics and issues around product disclosure as barriers to PrEP use [45].”
BackgroundResultBekker, L., Roux, S., Sebastien, E., Yola, N., Amico, K. R., Hughes, J. P., Marzinke, M. A., Hendrix, C. W., Anderson, P. L., Elharrar, V., et al. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30156-x · Cited by 125
Self-citationMustanski, B. S., Ryan, D. T., Hayford, C. S., Phillips, G., Newcomb, M. E., & Smith, J. D. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2159-5 · Cited by 119 · cited 1×
“Moreover experiences with PrEP-related stigma and disclosure could dynamically shift over time as community knowledge of PrEP increases [20,31,32].”
BackgroundBekker, L., Rebe, K. B., Venter, F., Maartens, G., Moorhouse, M. A., Conradie, F., Wallis, C. L., Black, V., Harley, B., & Eakle, R. (2016) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v17i1.455 · Cited by 109
Self-citationFranks, J. C., Hirsch‐Moverman, Y., Loquere, A., Amico, K. R., Grant, R. M., Dye, B. J., Rivera, Y., Gamboa, R., & Mannheimer, S. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1964-6 · Cited by 109
Brooks, R. A., Nieto, O., Landrian, A. S., Fehrenbacher, A. E., & Cabral, A. (2019) · Journal of Urban Health · doi:10.1007/s11524-019-00371-3 · Cited by 96 · cited 1×
“We hypothesized that this sample size would be adequate to achieve saturation of key themes based on qualitative work investigating similar issues of stigma and disclosure among new PrEP users [18,34,35].”
BackgroundGlobal PrEP roll-out: recommendations for programmatic success
Amico, K. R., & Bekker, L. (2019) · The Lancet HIV · doi:10.1016/s2352-3018(19)30002-5 · Cited by 93 · cited 3×
“Moreover experiences with PrEP-related stigma and disclosure could dynamically shift over time as community knowledge of PrEP increases [20,31,32].”
BackgroundSelf-citationHodges-Mameletzis, I., Dalal, S., Msimanga-Radebe, B., Rodolph, M., & Baggaley, R. C. (2018) · Sexual Health · doi:10.1071/sh18125 · Cited by 92 · cited 1×
“Increasing numbers of PrEP users and wordof-mouth information about PrEP created local pockets of PrEP awareness among AGYW in our study settings which may have influenced stigma and disclosure experiences [20,48,49].”
BackgroundPintye, J. C., Kinuthia, J., Roberts, D. A., Wagner, A. D., Mugwanya, K. K., Abuna, F., Lagat, H., Owiti, G., Levin, C., Barnabas, R. V., et al. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001850 · Cited by 85
Demographic Differences in PrEP-Related Stereotypes: Implications for Implementation
Golub, S. A., Gamarel, K. E., & Surace, A. (2015) · AIDS and Behavior · doi:10.1007/s10461-015-1129-4 · Cited by 83
Biello, K. B., Oldenburg, C. E., Mitty, J. A., Closson, E. F., Mayer, K. H., Safren, S. A., & Mimiaga, M. J. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1466-y · Cited by 79
Rosenberg, N. E., Bhushan, N. L., Vansia, D., Phanga, T., Maseko, B., Nthani, T., Libale, C., Bamuya, C., Kamtsendero, L., Kachigamba, A., et al. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001830 · Cited by 76
Self-citationPrEP on Twitter: Information, Barriers, and Stigma
Schwartz, J., & Grimm, J. (2016) · Health Communication · doi:10.1080/10410236.2016.1140271 · Cited by 76 · cited 1×
“In-person and social media campaigns that brand PrEP around wellness and empowerment, rather than HIV risk and sexual behaviour, have the potential to counter stigmatizing narratives around PrEP [20,54,55].”
BackgroundPr EP interest and HIV ‐1 incidence among MSM and transgender women in coastal Kenya
Kimani, M., van der Elst, E., Chirro, O., Oduor, C., Wahome, E., Kazungu, W., Shally, M., de Wit, T. F. R., Graham, S. M., Operario, D., et al. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25323 · Cited by 70
Biello, K. B., Marrow, E., Mimiaga, M. J., Sullivan, P. S., Hightow‐Weidman, L., & Mayer, K. H. (2019) · JMIR Research Protocols · doi:10.2196/10694 · Cited by 69
Atujuna, M., Newman, P. A., Wallace, M., Eluhu, M., Rubincam, C., Brown, B. B., & Bekker, L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191251 · Cited by 61
Self-citationBrooks, R. A., Cabral, A., Nieto, O., Fehrenbacher, A. E., & Landrian, A. S. (2019) · Transgender Health · doi:10.1089/trgh.2019.0014 · Cited by 57 · cited 1×
“We hypothesized that this sample size would be adequate to achieve saturation of key themes based on qualitative work investigating similar issues of stigma and disclosure among new PrEP users [18,34,35].”
BackgroundPintye, J. C., Beima‐Sofie, K., Makabong’o, P., Njoroge, A., Trinidad, S. B., Heffron, R. A., Baeten, J. M., Celum, C., Matemo, D. N., Kinuthia, J., et al. (2018) · AIDS Patient Care and STDs · doi:10.1089/apc.2018.0058 · Cited by 55
Self-citationEakle, R., Bothma, R., Bourne, A. H., Gumede, S., Motsosi, K., & Rees, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212271 · Cited by 48
Magno, L., Dourado, I. C., Coats, C. S., Wilhite, D., da Silva, L. A. V., Oni-Orisan, O., Brown, J., Soares, F., Kerr, L. R. F. S., Ransome, Y., et al. (2019) · Global Public Health · doi:10.1080/17441692.2019.1571090 · Cited by 35 · cited 1×
“In-person and social media campaigns that brand PrEP around wellness and empowerment, rather than HIV risk and sexual behaviour, have the potential to counter stigmatizing narratives around PrEP [20,54,55].”
BackgroundIdoko, J. A., Foláyan, M. O., Dadem, N. Y., Kolawole, G. O., Anenih, J. O., & Alhassan, E. O. (2015) · BMC Public Health · doi:10.1186/s12889-015-1690-9 · Cited by 32 · cited 1×
“Similar concerns about stigma and disclosure have been described in programmatic PrEP delivery settings among heterosexual HIV serodiscordant couples in Nigeria and MSM in the United States, particularly when PrEP is explicitly marketed for “high-risk populations” [14,46,47].”
BackgroundWomen and ARV‐based HIV prevention – challenges and opportunities
Geary, C. W., & Bukusi, E. A. (2014) · Journal of the International AIDS Society · doi:10.7448/ias.17.3.19356 · Cited by 28
Velloza, J., Delany‐Moretlwe, S., & Baeten, J. M. (2019) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000567 · Cited by 24
Self-citation
Cited by
Delany-Moretlwe, S., Hughes, J. P., Bock, P., Ouma, S. G., Hunidzarira, P., Kalonji, D., Kayange, N., Makhema, J., Mandima, P., Mathew, C., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00538-4 · Cited by 586
Self-citation
Metadata
- Authors
- Velloza, J., Khoza, N., Scorgie, F., Chitukuta, M., Mutero, P., Mutiti, K., Mangxilana, N., Nobula, L., Bulterys, M. A., Atujuna, M., Hosek, S., Heffron, R., Bekker, L., Mgodi, N., Chirenje, M., Celum, C., Delany‐Moretlwe, S., & for the HPTN 082 study group
- Venue
- Journal of the International AIDS Society
- Publisher
- Wiley
- Published
- 2020-03
- Volume
- 23
- Issue
- 3
- Pages
- e25463-e25463
- ISSN
- 1758-2652 (ISSN-L)
- OpenAlex
- W3010508615
- Cited by
- 214
- References
- 57
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.